TRAF3 and B-cell neoplasm: The latest report showed that transgenic mice overexpressing TRAF3 in B cells develop with high-incidence severe lymphadenopathy, splenomegaly, and lymphoid infiltrations into tissues and organs, which is the result of the growth of monoclonal and oligoclonal B cell neoplasms.